Tag archives: FDA
FDA Considerations Put Compounding Pharmacy Services at Risk
A recent report from the National Academies of Sciences, Engineering, and Medicine (NASEM) titled, “The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use,” has raised concerns for the staff of San Ysidro Pharmacy (SYP) and other compounding pharmacies around the nation. The report included a recommendation for across-the-board restrictions […]
Sewer Spending Spigot
Bob Hazard has again “hit the nail…” with his “What’s Up in the Sewer System” expose (Guest Editorial MJ # 25/38). How can we ascertain who appointed “those three” Sanitary Board members and change the system to all five elected in the future? No one in Santa Barbara media is performing investigative journalism like Mr. […]
